Colorectal cancer screening in evolution: Japan and the USA

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue SUPPL. 1, 2010, Pages

  Ross, William A ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer screening; Colonoscopy; Colorectal cancer

Indexed keywords

CANADA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; FECES ANALYSIS; HUMAN; IMMUNOCHEMISTRY; JAPAN; MEDICARE; PRIORITY JOURNAL; SCREENING TEST; SIMULATION; UNITED STATES; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE QUALITY; INCIDENCE; MASS SCREENING; PRACTICE GUIDELINE; PREDICTIVE VALUE; STATISTICAL MODEL; TIME; TRENDS;

CANADA; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HUMANS; INCIDENCE; JAPAN; MASS SCREENING; MODELS, ECONOMIC; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; QUALITY INDICATORS, HEALTH CARE; TIME FACTORS; UNITED STATES;

EID: 77951528011     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06221.x     Document Type: Conference Paper

References (84)

1. Minami Y, Nishino Y, Tsubono Y, Tsuji I, Hisamichi S. Increase of colon and rectal cancer incidence rates in Japan: trends in incidence rates in Miyagi Prefecture, 1959-1997. J. Epidemiol. 2006 16 : 240 248. (Pubitemid 44725559)
2. National Cancer Center: Center for Cancer Control and Information Services. Cancer Statistics in Japan '07. Cited 15 May 2009. Available from URL: http://ganjoho.ncc.go.jp/public/statistics/backnumber/2007-en.html
3. Bertagnolli MM, Eagle CJ, Zauber AG et al. Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev. Res. 2009 2 : 310 321.
4. Nelson RL, Persky V, Turyk M. Determination of factors responsible for the declining incidence of colorectal cancer. Dis. Colon. Rectum. 1999 42 : 741 752. (Pubitemid 29279426)
5. Joseph DA, Rim SH, Seeff LC. Use of colorectal cancer tests - United States, 2002, 2004, and 2006. MMWR Weekly (CDC) 2008 57 : 253 258.
6. Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur. J. Cancer Prev. 2004 13 : 127 132. (Pubitemid 38585332)
7. Kuriki K, Tajima K. The increasing incidence of colorectal cancer and the preventive strategy in Japan. Asian Pac. J. Cancer Prev. 2006 7 : 495 501.
8. Levin B, Lieberman DA, McFarland B et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008 134 : 1570 1595. (Pubitemid 351615355)
9. Morrison A. Screening in Chronic Disease.
10. Lieberman D. Colorectal cancer screening in primary care. Gastroenterology 2007 132 : 2591 2594. (Pubitemid 46890875)
11. Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. Trends in colorectal cancer mortality in Japan, 1970-2000. Int. J. Cancer 2005 113 : 339 341. (Pubitemid 41510132)
12. Coleman MP, Quaresma M, Berrino F et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008 9 : 730 756.
13. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin. 2008 58 : 71 96. (Pubitemid 351521864)
14. Simon JB. Occult blood screening for colorectal carcinoma: a critical review. Gastroenterology 1985 88 : 820 837. (Pubitemid 15130675)
15. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996 348 : 1472 1477. (Pubitemid 26400242)
16. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N. Engl. J. Med. 1993 328 : 1365 1371.
17. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J. Natl. Cancer Inst. 1992 84 : 1572 1575.
18. Selby JV, Friedman GD, Quesenberry CP Jr., Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N. Engl. J. Med. 1992 326 : 653 657.
19. Force USPST. Screening for colorectal cancer: recommendation and rationale. Ann. Intern. Med. 2002 137 : 129 131. (Pubitemid 34779158)
20. Force USPST. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann. Intern. Med. 2008 149 : 627 637.
21. Siegel R, Jemal A, Ward E. Colorectal Cancer Facts and Figures 2008-2010. Atlanta: American Cancer Society. Cited 7 May 2009. Available from URL: http://www.cancer.org/downloads/SST/F861708-finalforweb.pdf
22. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008 135 : 82 90.
23. Saito H, Soma Y, Nakajima M et al. A case-control study evaluating occult blood screening for colorectal cancer with hemoccult test and an immunochemical hemagglutination test. Oncol. Rep. 2000 7 : 815 819.
24. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S, Tsugane S. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan. Cancer Detect. Prev. 2007 31 : 3 11. (Pubitemid 46367446)
25. Devesa SS, Silverman DT, Young JL Jr. et al. Cancer incidence and mortality trends among whites in the United States, 1947-84. J. Natl. Cancer Inst. 1987 79 : 701 770.
26. Troisi RJ, Freedman AN, Devesa SS. Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994. Cancer 1999 85 : 1670 1676.
27. Devesa SS, Silverman DT. Cancer incidence and mortality trends in the United States: 1935-74. J. Natl. Cancer Inst. 1978 60 : 545 571. (Pubitemid 8303984)
28. Yiu HY, Whittemore AS, Shibata A. Increasing colorectal cancer incidence rates in Japan. Int. J. Cancer 2004 109 : 777 781. (Pubitemid 38405628)
29. Moore LL, Bradlee ML, Singer MR et al. BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults. Int. J. Obes. Relat. Metab. Disord. 2004 28 : 559 567.
30. Shimizu N, Nagata C, Shimizu H et al. Height, weight, and alcohol consumption in relation to the risk of colorectal cancer in Japan: a prospective study. Br. J. Cancer 2003 88 : 1038 1043. (Pubitemid 36560772)
31. Otani T, Iwasaki M, Inoue M. Body mass index, body height, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan public health center-based prospective study. Cancer Causes Control 2005 16 : 839 850. (Pubitemid 41160047)
32. Solomon MJ, McLeod RS. Periodic health examination, 1994 update: 2. Screening strategies for colorectal cancer. Canadian Task Force on the Periodic Health Examination. CMAJ 1994 150 : 1961 1970.
33. Canadian Task Force on Preventive Health Care. Colrectal cancer screening: recommendation statement from the Canadian Task Force on Preventive Health Care. Can. Med. Assoc. J. 2001 165 : 206 208.
34. Kielar AZ, El-Maraghi RH. Canadian colorectal cancer screening initiatives and barriers. J. Am. Coll. Radiol. 2008 5 : 951 957.
35. Rabeneck L, Paszat LF. A population-based estimate of the extent of colorectal cancer screening in Ontario. Am. J. Gastroenterol. 2004 99 : 1141 1144. (Pubitemid 38917821)
36. McGregor SE, Hilsden RJ, Li FX, Bryant HE, Murray A. Low uptake of colorectal cancer screening 3 yr after release of national recommendations for screening. Am. J. Gastroenterol. 2007 102 : 1727 1735. (Pubitemid 47206673)
37. Gupta AK, Melton LJ 3rd., Petersen GM et al. Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study. Clin. Gastroenterol. Hepatol. 2005 3 : 150 158. (Pubitemid 40220310)
38. Shida H, Ban K, Matsumoto M et al. Asymptomatic colorectal cancer detected by screening. Dis. Colon. Rectum. 1996 39 : 1130 1135. (Pubitemid 26330524)
39. Gross CP, Andersen MS, Krumholz HM, McAvay GJ, Proctor D, Tinetti ME. Relation between Medicare screening reimbursement and stage at diagnosis for older patients with colon cancer. JAMA 2006 296 : 2815 2822. (Pubitemid 44969181)
40. Rex DK, Eid E. Considerations regarding the present and future roles of colonoscopy in colorectal cancer prevention. Clin. Gastroenterol. Hepatol. 2008 6 : 506 514. (Pubitemid 351609452)
41. Sharma VK, Nguyen CC, Crowell MD, Lieberman DA, de Garmo P, Fleischer DE. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest. Endosc. 2007 66 : 27 34.
42. Rabeneck L, Paszat LF, Hilsden RJ et al. Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 2008 135 : 1899 1906, 906 e1.
43. Katsumura Y, Yasunaga H, Imamura T, Ohe K, Oyama H. Relationship between risk information on total colonoscopy and patient preferences for colorectal cancer screening options: analysis using the analytic hierarchy process. BMC Health Serv. Res. 2008 8 : 106. (Pubitemid 351794091)
44. Rex DK, Bond JH, Winawer S et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am. J. Gastroenterol. 2002 97 : 1296 1308. (Pubitemid 34664769)
45. Rex DK, Petrini JL, Baron TH et al. Quality indicators for colonoscopy. Gastrointest. Endosc. 2006 63 Suppl 4 S16 28.
46. Sawhney MS, Cury MS, Neeman N et al. Effect of institution-wide policy of colonoscopy withdrawal time > or = 7 minutes on polyp detection. Gastroenterology 2008 135 : 1892 1898.
47. Heresbach D, Barrioz T, Lapalus MG et al. Miss rate for colorectal neoplastic polyps: a prospective multicenter study of back-to-back video colonoscopies. Endoscopy 2008 40 : 284 290. (Pubitemid 351524375)
48. Baxter NN, Goldwasser MA, Paszat LF, Saskin R, Urbach DR, Rabeneck L. Association of colonoscopy and death from colorectal cancer. Ann. Intern. Med. 2009 150 : 1 8.
49. Vijan S, Hwang I, Inadomi J et al. The cost-effectiveness of CT colonography in screening for colorectal neoplasia. Am. J. Gastroenterol. 2007 102 : 380 390. (Pubitemid 46160552)
50. Rex DK, Cutler CS, Lemmel GT et al. Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 1997 112 : 24 8.
51. Bressler B, Paszat LF, Chen Z, Rothwell DM, Vinden C, Rabeneck L. Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis. Gastroenterology 2007 132 : 96 102. (Pubitemid 46108740)
52. Hosokawa O, Shirasaki S, Kaizaki Y, Hayashi H, Douden K, Hattori M. Invasive colorectal cancer detected up to 3 years after a colonoscopy negative for cancer. Endoscopy 2003 35 : 506 510. (Pubitemid 36705642)
53. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N. Engl. J. Med. 2006 355 : 2533 2541.
54. Chen SC, Rex DK. Endoscopist can be more powerful than age and male gender in predicting adenoma detection at colonoscopy. Am. J. Gastroenterol. 2007 102 : 856 861. (Pubitemid 46496608)
55. Millan MS, Gross P, Manilich E, Church JM. Adenoma detection rate: the real indicator of quality in colonoscopy. Dis. Colon. Rectum. 2008 51 : 1217 1220.
56. Pickhardt PJ, Hanson ME, Vanness DJ et al. Unsuspected extracolonic findings at screening CT colonography: clinical and economic impact. Radiology 2008 249 : 151 159.
57. Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JD. At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int. J. Cancer 2009 124 : 1161 1168.
58. Hassan C, Pickhardt PJ, Laghi A et al. Computed tomographic colonography to screen for colorectal cancer, extracolonic cancer, and aortic aneurysm: model simulation with cost-effectiveness analysis. Arch. Intern. Med. 2008 168 : 696 705. (Pubitemid 351563952)
59. Zauber AG, Knudsen AB, Rutter CM et al. Cost-effectiveness of CT colonography to screen for colorectal cancer. Agency Healthcare Research and Quality Technical Assessment Report. Nov 22, 2008. 2009 Cited 17 April 2009. Available from URL: http://www.1cms.hhs.gov/mcd/viewtechassess.asp?from2= viewtechassess.asp&where=index&tid=58&
60. Ristvedt SL, McFarland EG, Weinstock LB, Thyssen EP. Patient preferences for CT colonography, conventional colonoscopy, and bowel preparation. Am. J. Gastroenterol. 2003 98 : 578 585.
61. Svensson MH, Svensson E, Lasson A, Hellstrom M. Patient acceptance of CT colonography and conventional colonoscopy: prospective comparative study in patients with or suspected of having colorectal disease. Radiology 2002 222 : 337 345. (Pubitemid 34106101)
62. Graser A, Stieber P, Nagel D, Schafer C, Horst D, Becker CR et al. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut 2009 58 : 241 248.
63. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2008 149 : 659 669.
64. Fisher JA, Fikry C, Troxel AB. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines. Cancer Epidemiol. Biomarkers Prev. 2006 15 : 108 113.
65. Braithwaite RS, Meltzer DO, King JT Jr., Leslie D, Roberts MS. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? Med. Care 2008 46 : 349 356.
66. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N. Engl. J. Med. 1993 329 : 1977 1981.
67. Ransohoff DF. How much does colonoscopy reduce colon cancer mortality? Ann. Intern. Med. 2009 150 : 50 2.
68. Cooper GS. Colonoscopy: a tarnished gold standard? Gastroenterology 2007 132 : 2588 2590.
69. Shah HA, Paszat LF, Saskin R, Stukel TA, Rabeneck L. Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology 2007 132 : 2297 2303. (Pubitemid 46890860)
70. Kahi CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality. Clin. Gastroenterol. Hepatol. 2009 7 : 770 775 quiz 11.
71. Robertson DJ. Is screening colonoscopy effective in preventing cancer? Some answers, more questions. Clin. Gastroenterol. Hepatol. 2009 7 : 714 715.
72. Leung K, Pinsky P, Laiyemo AO, Lanza E, Schatzkin A, Schoen RE. Ongoing colorectal cancer risk despite surveillance colonoscopy: the Polyp Prevention Trial Continued Follow-up Study. Gastrointest. Endosc. 2009 Epub ahead of print EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2008 149 : 638 658.
73. Ahlquist DA, Sargent DJ, Loprinzi CL et al. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann. Intern. Med. 2008 149 : 441 450. W81.
74. Sieg A, Friedrich K, Sieg U. Is PillCam COLON capsule endoscopy ready for colorectal cancer screening? A prospective feasibility study in a community gastroenterology practice. Am. J. Gastroenterol. 2009 104 : 848 854.
75. Segnan N, Senore C, Andreoni B et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J. Natl. Cancer Inst. 2005 97 : 347 357. (Pubitemid 40425953)
76. Scott RG, Edwards JT, Fritschi L, Foster NM, Mendelson RM, Forbes GM. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am. J. Gastroenterol. 2004 99 : 1145 1151. (Pubitemid 38917822)
77. Harewood GC, Lieberman DA. Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening. Clin. Gastroenterol. Hepatol. 2004 2 : 72 7.
78. Phillips KA, Liang SY, Ladabaum U et al. Trends in colonoscopy for colorectal cancer screening. Med. Care 2007 45 : 160 167.
79. Brenner H, Hoffmeister M, Brenner G, Altenhofen L, Haug U. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur. J. Cancer 2009 45 : 2027 2033.
80. Subramanian S, Bobashev G, Morris RJ. Modeling the cost-effectiveness of colorectal cancer screening: policy guidance based on patient preferences and compliance. Cancer Epidemiol. Biomarkers Prev. 2009 18 : 1971 1978.
81. Arditi C, Peytremann-Bridevaux I, Burnand B et al. Appropriateness of colonoscopy in Europe (EPAGE II). Screening for colorectal cancer. Endoscopy 2009 41 : 200 208.
82. Agrawal S, Bhupinderjit A, Bhutani MS et al. Colorectal cancer in African Americans. Am. J. Gastroenterol. 2005 100 : 515 523 discussion 4. (Pubitemid 40487546)
83. Walter LC, Lindquist K, Nugent S et al. Impact of age and comorbidity on colorectal cancer screening among older veterans. Ann. Intern. Med. 2009 150 : 465 473.
84. Zou H, Harrington JJ, Shire AM et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol. Biomarkers Prev. 2007 16 : 2686 2696. (Pubitemid 351196325)